ondansetron has been researched along with Acute Post-Traumatic Stress Disorder in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Michopoulos, V | 1 |
| Maples-Keller, J | 1 |
| Roger, EI | 1 |
| Beaudoin, FL | 1 |
| Sumner, JA | 1 |
| Rothbaum, BO | 1 |
| Hudak, L | 1 |
| Gillespie, CF | 1 |
| Kronish, IM | 1 |
| McLean, SA | 1 |
| Ressler, KJ | 1 |
1 other study available for ondansetron and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Nausea in the peri-traumatic period is associated with prospective risk for PTSD symptom development.
Topics: Adolescent; Adult; Antiemetics; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Ondans | 2019 |